Welcome to CDC stacks | Health Care Use and Opportunities for Human Papillomavirus Vaccination Among Young Men Who Have Sex With Men - 36901 | CDC Public Access
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
Health Care Use and Opportunities for Human Papillomavirus Vaccination Among Young Men Who Have Sex With Men
Filetype[PDF-204.05 KB]


Details:
No Related Documents.
You May Also Like:
  1. Increasing Human Papillomavirus Vaccine Coverage Among Men Who Have Sex With Men—National HIV Behavioral Surveillance, United States, 2014
    Personal Author:
    Oliver, Sara E.; Hoots, Brooke E.; Paz-Bailey, Gabriela; Markowitz, Lauri E.; Meites, Elissa;
    Corporate Author:
    for the NHBS Study Group
    Published:
    Jul 01 2017
    Source:
    J Acquir Immune Defic Syndr. 75(Suppl 3):S370-S374.
    Description:
    Background : Human papillomavirus (HPV) can cause oropharyngeal and anogenital cancers among men who have sex with men (MSM). In 2011, the Advisory Committee on Immunization Practices (ACIP) extended HPV vaccine recommendations to males through age 2...
    File Type:
    Filetype[PDF - 319.18 KB]
  2. HPV vaccine coverage among men who have sex with men – National HIV Behavioral Surveillance System, United States, 2011
    Personal Author:
    Meites, Elissa; Markowitz, Lauri E.; Paz-Bailey, Gabriela; Oster, Alexandra M.;
    Published:
    Sep 22 2014
    Source:
    Vaccine. 32(48):6356-6359.
    Description:
    Men who have sex with men (MSM) are at high risk for disease associated with human papillomavirus (HPV). In late 2011, HPV vaccine was recommended for males through age 21 and MSM through age 26. Using data from the 2011 National HIV Behavioral Surve...
    File Type:
    Filetype[PDF - 153.91 KB]
  3. Human papillomavirus (HPV) vaccine initiation and HPV and vaccine awareness among men 18–26 years in the United States, 2010
    Personal Author:
    Lu, Peng-jun; Williams, Walter W.; Li, Jun; Dorell, Christina; Yankey, David; Kepka, Deanna; Dunne, Eileen F.;
    Published:
    Apr 2013
    Source:
    Am J Prev Med. 44(4):330-338.
    Description:
    Background : In 2009, the quadrivalent Human Papillomavirus (HPV) vaccine was licensed by the Food and Drug Administration (FDA) for use in males 9 through 26 years. In 2009, the Advisory Committee on Immunization Practices (ACIP) provided a permissi...
    File Type:
    Filetype[PDF - 360.55 KB]
  4. Human Papillomavirus Vaccination Coverage Among Adolescent Girls, 2007–2012, and Postlicensure Vaccine Safety Monitoring, 2006–2013 — United States
    Personal Author:
    Stokley, Shannon; Curtis, C. Robinette; Jeyarajah, Jenny; Harrington, Theresa; Gee, Julianne; Markowitz, Lauri;
    Published:
    Jul 26 2013
    Source:
    MMWR Morb Mortal Wkly Rep. 2013; 62(29):591-595.
    Description:
    Since mid-2006, the Advisory Committee on Immunization Practices (ACIP) has recommended routine vaccination of adolescent girls at ages 11 or 12 years with 3 doses of human papillomavirus (HPV) vaccine. Two HPV vaccines are currently available in the...
    File Type:
    Filetype[PDF - 206.36 KB]
  5. Barriers to Human Papillomavirus Vaccination Among US Adolescents
    Personal Author:
    Holman, Dawn M.; Benard, Vicki; Roland, Katherine B.; Watson, Meg; Liddon, Nicole; Stokley, Shannon;
    Published:
    Jan 2014
    Source:
    JAMA Pediatr. 168(1):76-82.
    Description:
    IMPORTANCE : Since licensure of the human papillomavirus (HPV) vaccine in 2006, HPV vaccine coverage among US adolescents has increased but remains low compared with other recommended vaccines. : OBJECTIVE : To systematically review the literature on...
    File Type:
    Filetype[PDF - 207.84 KB]